Patent Assignment
Reel/Frame 019047/0317
Patent Security Agreement First Lien
Recorded: 2007-03-22
Received: 2007-03-22
Pages: 20
Assignors
PRECISION PHARMA SERVICES, INC.
Executed: 2006-12-06
TALECRIS BIOTHERAPEUTICS HOLDINGS CORP.
Executed: 2006-12-06
TALECRIS BIOTHERAPEUTICS, INC.
Executed: 2006-12-06
TALECRIS PLASMA RESOURCES, INC.
Executed: 2006-12-06
Assignee
MORGAN STANLEY SENIOR FUNDING, INC., AS THE ADMINISTRATIVE AGENT
1585 BROADWAY, NEW YORK, NY, 10036, UNITED STATES
Covered Properties
(16)
Recombinantly Modified Plasmin
Application:
11/568,023 →
Apparatus and method for handling and opening a frangible container
Application:
11/470,390 →
Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
Application:
11/402,259 →
Methods and compositions for treating herpes infections
Application:
11/367,772 →
Method of treatment and prophylaxis using IgM
Application:
60/763,422 →
Alkyl benzamides
Application:
11/244,787 →
Halogenated Benzamide Derivatives
Application:
11/221,256 →
Combination chemotherapy for helminth infections
Application:
10/770,274 →
Process for the Production of a Reversibly Inactive Acidified Plasmin Composition
Application:
10/692,105 →
Methods and Compositions for Treating Herpes Infections
Application:
10/656,781 →
Method of Thrombolysis by Local Delivery of Reversibly Inactivated Acidified Plasmin
Application:
10/280,444 →
Process for the production of a reversibly inactive acidified plasmin composition
Application:
10/143,156 →
Reversibly inactivated acidified plasmin
Application:
10/143,112 →
Method of Thrombolysis by Local Delivery of Reversibly Inactivated Acidified Plasmin
Application:
10/143,157 →
Method of Using Pon-1 to Decrease Atheroma Formation
Application:
10/105,640 →
Method of Forming Zero Marks
Application:
09/884,204 →